Letter: immunogenicity of anti-TNF in elderly IBD patients

Aliment Pharmacol Ther. 2019 Aug;50(3):336. doi: 10.1111/apt.15312.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adalimumab
  • Aged
  • Crohn Disease*
  • Humans
  • Infliximab
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab